The incidence of isolated anterior cruciate ligament (ACL) tears is 68.6 per 100,000 person-years.^[@bibr34-2325967120915698]^ ACL-deficient knees may cause chronic knee instability, cartilage injuries, and complex unrepairable meniscal tears.^[@bibr18-2325967120915698],[@bibr26-2325967120915698],[@bibr40-2325967120915698]^ Affected patients are required to give up the practice of highly demanding sports, reduce their workload, and even adopt a sedentary lifestyle, which directly affects their quality of life. With improvements in instrumental and surgical techniques, arthroscopic ACL reconstruction (ACLR) has demonstrated promising clinical outcomes.^[@bibr17-2325967120915698]^ In terms of societal and economic impacts, arthroscopic ACLR is more cost-effective than nonoperative treatment.^[@bibr25-2325967120915698]^ Therefore, ACLR has become the mainstay of treatment for ACL insufficiency in young and active patients and for those who fail nonoperative therapy or do not want to change an active lifestyle.^[@bibr22-2325967120915698],[@bibr31-2325967120915698]^

The treatment for ACL injuries in middle-aged patients remains controversial. Because older patients may not perform highly demanding activities and they may have inferior surgical outcomes due to pre-existing knee chondral injuries, nonoperative treatment is usually preferred. However, with a longer life expectancy and improved physiological health, older people participate in more physically demanding sports than previously.^[@bibr3-2325967120915698],[@bibr6-2325967120915698]^ In addition, because nonoperative treatment for ACL injuries was reported to be associated with a relatively high risk for reinjuries and residual instability,^[@bibr9-2325967120915698]^ more middle-aged patients have undergone ACLR to prevent decreased knee function and to maintain an active lifestyle.^[@bibr37-2325967120915698],[@bibr41-2325967120915698]^

Previous studies have mainly focused on patients older than 40 years, finding similar clinical outcomes between patients older than 40 years and those younger than 25 years after ACLR.^[@bibr21-2325967120915698],[@bibr23-2325967120915698]^ Although several studies have reported no significant difference in clinical outcomes after ACLR between patients older than 50 years and young patients,^[@bibr3-2325967120915698],[@bibr17-2325967120915698],[@bibr32-2325967120915698]^ few have systematically reviewed the literature to compare the benefits and adverse outcomes of ACLR between these patient groups.

In this study, we systematically evaluated the outcomes of ACLR in patients older than 50 years. Our hypothesis was that patients older than 50 years would have outcomes comparable to those of patients younger than 50 years after arthroscopic ACLR.

Methods {#section1-2325967120915698}
=======

Search Strategy {#section2-2325967120915698}
---------------

The reporting in this systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.^[@bibr30-2325967120915698]^ Studies that included patients who underwent arthroscopic ACLR and compared patients older than 50 years with those younger than 50 years were eligible for inclusion. We searched for relevant studies in the Cochrane Central Register of Controlled Trials (CENTRAL), Embase, and MEDLINE databases from inception to April 30, 2019 using the following keywords: "anterior cruciate ligament" and "age." We used both MeSH terms and free text and utilized Boolean operators to combine them in searching. The search strategy is detailed in the [Appendix.](#app1-2325967120915698){ref-type="app"} Furthermore, we checked ongoing studies on this topic from the United States National Institutes of Health trial registry (<http://clinicaltrials.gov>). Moreover, we contacted experts in this specialty for any ongoing investigations or unpublished data on this issue. In addition, we went through the references of potential studies for potentially eligible trials. No language restriction was applied.

Selection Criteria {#section3-2325967120915698}
------------------

We included studies that (1) were randomized controlled trials or comparative studies and (2) compared the outcomes of patients older than 50 years and those younger than 50 years after arthroscopic ACLR. We excluded (1) studies that involved revision surgery without separate data, (2) nonhuman studies, (3) single-arm case series without a control group, and (4) studies with no usable data. After removing duplicates, 2 authors (C.-W.T. and L.-T.K.) independently selected studies according to the inclusion criteria. Irrelevant studies were eliminated after checking the titles and abstracts, then the full text of potentially relevant studies was obtained. We also confirmed the inclusion of these studies after checking the full text against the inclusion and exclusion criteria. Disputes were resolved through discussion, and the opinion of a third author (C.-C.C.) was requested if necessary.

Data Extraction {#section4-2325967120915698}
---------------

There were 2 authors (C.-W.T. and L.-T.K.) who independently extracted data from the included studies using a standardized data collection form. The following information was included: first author, year of publication, study design (patient selection and concealment), details of the participants (eg, number, age, and sex), type of tendon graft, fixation device for the tendon graft, and outcome data, which included functional scores, knee anteroposterior (AP) stability, and adverse events. A third author (C.-C.C.) arbitrated when the 2 authors disagreed.

The primary outcome was knee function, measured by functional scores. Our secondary outcomes included knee AP stability as measured using an arthrometer, as well as adverse events, including arthrofibrosis and the need for secondary procedures.

Quality Assessment {#section5-2325967120915698}
------------------

The same 2 authors (C.-W.T. and L.-T.K.) independently evaluated the risk of bias of the included randomized controlled trials using The Cochrane Collaboration's tool.^[@bibr12-2325967120915698],[@bibr13-2325967120915698]^ A third author (C.-C.C.) arbitrated when the 2 authors disagreed. We used the Methodological Index for Non-randomized Studies (MINORS) to assess the methodological quality of nonrandomized studies.^[@bibr39-2325967120915698]^

The same 2 authors independently evaluated the quality of the body of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.^[@bibr36-2325967120915698]^ We assessed 5 domains and rated the strength of evidence for each outcome (GRADEpro, Version 2.0; McMaster University).^[@bibr10-2325967120915698]^

Data Synthesis and Statistical Analysis {#section6-2325967120915698}
---------------------------------------

We conducted a random-effects meta-analysis for all outcomes to address the expected inherent clinical heterogeneity among the included studies.^[@bibr7-2325967120915698]^ Data were expressed as the risk ratio (RR) with a 95% confidence interval (CI) for dichotomous data and as the mean difference (MD) or standardized MD with a 95% CI for continuous data. A *P* value \<.05 was considered statistically significant. Chi-square and *I* ^2^ statistics were used to assess statistical heterogeneity with a level of significance set at *P* \< .10. *I* ^2^ values of 0.0%-24.9%, 25.0%-49.9%, 50.0%-74.9%, and 75.0%-100.0% indicated no, low, moderate, and high heterogeneity, respectively.^[@bibr14-2325967120915698],[@bibr15-2325967120915698]^ A subgroup analysis was performed if there was significant heterogeneity. In addition, between-study variance was estimated using tau-square (τ^2^) statistics.^[@bibr13-2325967120915698]^ We calculated the mean and variance from the reported median, range, and sample size if the standard deviation of continuous data was not reported in the published article.^[@bibr16-2325967120915698]^ When the standard deviation and range were not available, variance was estimated from the *P* value using the *t* test. If there were no raw data for analysis, we used a software program to extract the details from published graphs.^[@bibr29-2325967120915698]^ Forest plots were used to report the synthetic results. Review Manager 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration) was used for the meta-analysis.

Results {#section7-2325967120915698}
=======

Study Selection {#section8-2325967120915698}
---------------

A total of 2855 records were identified after searching the CENTRAL, MEDLINE, and Embase databases ([Figure 1](#fig1-2325967120915698){ref-type="fig"}). An additional record was identified from the references of an included study, and no ongoing trials were detected after searching the trial registry and consulting specialists. We eliminated 953 duplicates, leaving 1903 records. Of these, 1859 records were excluded after checking their titles and abstracts. After checking the full text of the remaining 44 studies against the inclusion and exclusion criteria, 40 records were excluded, 19 for not having separate data, 12 for lack of a control group, and the remaining 9 for other reasons. Ultimately, 4 nonrandomized studies were included in this review ([Figure 1](#fig1-2325967120915698){ref-type="fig"}).^[@bibr3-2325967120915698],[@bibr17-2325967120915698],[@bibr20-2325967120915698],[@bibr32-2325967120915698]^

![PRISMA flow diagram of the study.](10.1177_2325967120915698-fig1){#fig1-2325967120915698}

The 4 included studies,^[@bibr3-2325967120915698],[@bibr17-2325967120915698],[@bibr20-2325967120915698],[@bibr32-2325967120915698]^ consisted of 287 participants (129 in the older group and 158 in the younger group) ([Table 1](#table1-2325967120915698){ref-type="table"}). These studies were published between 2011 and 2019, and their sample size ranged from 40 to 90 participants. All included studies examined patients with ACL deficiency who underwent arthroscopic ACLR. With the exception of Cinque et al,^[@bibr3-2325967120915698]^ the studies excluded patients with high-grade (grade 3 or 4) chondral injuries,^[@bibr17-2325967120915698]^ advanced osteoarthritis (OA) (joint space narrowing \>50%),^[@bibr20-2325967120915698],[@bibr32-2325967120915698]^ and multiple ligament injuries. One study^[@bibr32-2325967120915698]^ included patients with acute ACL deficiency; another study^[@bibr20-2325967120915698]^ included patients with chronic ACL deficiency; and the third study^[@bibr3-2325967120915698]^ included both patients with acute and chronic ACL deficiency, although the distribution across the 2 groups did not differ. Most of the included studies evaluated patients for more than 2 years,^[@bibr3-2325967120915698],[@bibr17-2325967120915698],[@bibr32-2325967120915698]^ except for Kim et al,^[@bibr20-2325967120915698]^ who evaluated patients for 1 year only. The details of patient characteristics, as well as the inclusion and exclusion criteria, are presented in [Table 1](#table1-2325967120915698){ref-type="table"}.

###### 

Characteristics of Included Studies*^a^*

![](10.1177_2325967120915698-table1)

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author (Year)                              Inclusion and Exclusion Criteria                                                                                                             Patients (M/F), n   Age,*^b^* y       Time to Surgery,*^c^* mo   Follow-up,*^d^* mo   Outcomes                                                                                                                              Quality*^e^*
  ------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------- ------------------- ----------------- -------------------------- -------------------- ------------------------------------------------------------------------------------------------------------------------------------- --------------
  Osti^[@bibr32-2325967120915698]^ (2011)    Inclusion: ACL deficiency\                                                                                                                   O: 20 (12/8)\       O: 56 (50-62)\    O: 2.87 (2.40-3.33)\       O: 32 (24-49)\       Lysholm, IKDC, AP laxity (KT-1000 arthrometer), radiological evaluation, physical examination (Lachman, pivot shift), complications   14/24
                                             Exclusion: previous knee surgery or lower limb fracture, severe OA (joint space narrowing \>50%), severe associated ligament injury          Y: 20 (12/8)        Y: 27 (17-30)     Y: 2.80 (2.37-3.13)        Y: 33 (24-44)                                                                                                                                              

  Cinque^[@bibr3-2325967120915698]^ (2017)   Inclusion: age 20-30 and 50-70 y, ACL deficiency\                                                                                            O: 33 (14/19)\      O: 56 (50-62)\    O: 21 acute/12 chronic\    O: 37.2 Y: 40.8      SF-12, WOMAC, Lysholm, IKDC, Tegner, complications                                                                                    20/24
                                             Exclusion: previous knee infection or fracture, previous cartilage or meniscal surgery                                                       Y: 52 (33/19)       Y: 27 (17-30)     Y: 30 acute/22 chronic                                                                                                                                                                

  Iorio^[@bibr17-2325967120915698]^ (2018)   Inclusion: age \>50 y, ACL deficiency\                                                                                                       O: 36 (28/8)\       O: 54.0 ± 3.69\   N/A                        O: 64 (60-72)\       Lysholm, IKDC, Tegner, AP laxity (KT-1000 arthrometer), OA change (radiological evaluation), mean time to return to sports            19/24
                                             Exclusion: severe associated ligament injury other than ACL, grade 3 or 4 cartilage damage,*^f^* BMI \>29.9 kg/m^2^, previous knee surgery   Y: 36 (25/11)       Y: 32.5 ± 2.73                               Y: 78 (60-84)                                                                                                                                              

  Kim^[@bibr20-2325967120915698]^ (2019)     Inclusion: ACL deficiency\                                                                                                                   O: 40 (40/0)\       O: 52.8 ± 2.5\    O: 23.8 (16.5-30.1)\       O: 12\               Lysholm, IKDC, AP laxity (KT-2000 arthrometer), isokinetic strength                                                                   19/24
                                             Exclusion: previous ACL surgery, multiple knee ligament injury, ipsilateral lower limb surgery, severe OA (joint space narrowing \>50%)      Y: 50 (50/0)        Y: 28.9 ± 5.1     Y: 20.5 (12.4-28.7)        Y: 12                                                                                                                                                      
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*^a^*ACL, anterior cruciate ligament; AP, anteroposterior; BMI, body mass index; F, female; IKDC, International Knee Documentation Committee; M, male; N/A, not available; O, older group; OA, osteoarthritis; SF-12, Short Form--12; WOMAC, Western Ontario and McMaster Universities Arthritis Index; Y, younger group.

*^b^*Expressed as mean ± SD or median (range).

*^c^*Expressed as No. or mean (95% CI).

*^d^*Expressed as mean, or median (range).

*^e^*Evaluated according to the Methodological Index for Non-randomized Studies (MINORS).

*^f^*Evaluated using the Outerbridge classification.

Single-bundle ACLR was used as the surgical technique in all of the included studies. The transtibial femoral tunnel drilling technique was used in 1 study,^[@bibr32-2325967120915698]^ whereas the anteromedial femoral tunnel drilling technique was used in the remaining 3 studies.^[@bibr3-2325967120915698],[@bibr17-2325967120915698],[@bibr20-2325967120915698]^ Also, 3 of the included studies reported information on the tendon grafts. A gracilis and semitendinosus tendon (GST) autograft was used in 2 of the included studies,^[@bibr17-2325967120915698],[@bibr20-2325967120915698]^ and a bone--patellar tendon--bone (BPTB) autograft and allograft were both used in the study by Cinque et al.^[@bibr3-2325967120915698]^ Additional surgical details are presented in [Table 2](#table2-2325967120915698){ref-type="table"}.

###### 

Surgical Details of Included Studies*^a^*

![](10.1177_2325967120915698-table2)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author (Year)                              Associated Cartilage*^b^* or Ligamentous Injury, n   Meniscal Injury\        Graft Type                                Tunnel Technique             Fixation Method
                                                                                                  (Repair/Resection), n                                                                          
  ------------------------------------------ ---------------------------------------------------- ----------------------- ----------------------------------------- ---------------------------- -------------------------------------------------------
  Osti^[@bibr32-2325967120915698]^ (2011)    O: 1 I/3 II/4 III/2 IV\                              O: 11 (1/10)\           N/A                                       Transtibial single bundle    N/A
                                             Y: 1 I/3 II/1 III/0 IV                               Y: 8 (2/6)                                                                                     

  Cinque^[@bibr3-2325967120915698]^ (2017)   O: 17 I/6 II/6 III/4 IV\                             O: 31 (16/15)\          O: 18 BPTB allograft/15 BPTB autograft\   Anteromedial single bundle   Femur: cannulated titanium interference screw\
                                             Y: 43 I/2 II/6 III/1 IV\                             Y: 42 (30/12)           Y: 19 BPTB allograft/33 BPTB autograft                                 Tibia: cannulated titanium interference screw
                                             Concomitant ligament injury:\                                                                                                                       
                                             O: 14 FCL/6 MCL\                                                                                                                                    
                                             Y: 7 FCL/5 MCL                                                                                                                                      

  Iorio^[@bibr17-2325967120915698]^ (2018)   N/A                                                  N/A                     Double GST autograft                      Anteromedial single bundle   Femur: Swing-Bridge device\
                                                                                                                                                                                                 Tibia: Evolgate device

  Kim^[@bibr20-2325967120915698]^ (2019)     N/A                                                  O: 37 (21/16)\          Quadruple GST autograft                   Anteromedial single bundle   Femoral: cortical suspensory device (Endobutton CL)\
                                                                                                  Y: 41 (29/12)                                                                                  Tibia: bioabsorbable interference screw with post tie
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*^a^*BPTB, bone--patellar tendon--bone; FCL, fibular collateral ligament; GST, gracilis and semitendinosus tendon; MCL, medial collateral ligament; N/A, not available; O, older group; Y, younger group.

*^b^*Evaluated using the Outerbridge classification.

Study Quality {#section9-2325967120915698}
-------------

All included studies were nonrandomized controlled studies, and the risk of bias within the studies was analyzed according to the MINORS.^[@bibr39-2325967120915698]^ The scores varied from 14 to 20 (median, 19) for comparative studies (maximum score, 24). Most studies had a clear aim and appropriate endpoints; however, the unbiased endpoint assessment and prospectively calculated sample size were rarely mentioned ([Table 1](#table1-2325967120915698){ref-type="table"}).

IKDC Score {#section10-2325967120915698}
----------

A summary of all results from the meta-analysis is presented in [Table 3](#table3-2325967120915698){ref-type="table"}. All 4 included studies reported preoperative and postoperative International Knee Documentation Committee (IKDC) scores for the 2 groups. The older and younger groups had similar preoperative IKDC scores among all included studies. The meta-analysis revealed that the younger group had a significantly higher IKDC score than the older group at the end of follow-up (MD, −2.18 \[95% CI −4.29 to −0.07\]; *P* = .04) ([Figure 2A](#fig2-2325967120915698){ref-type="fig"} and [Table 3](#table3-2325967120915698){ref-type="table"}). No significant difference in the improvement of IKDC scores was noted between the younger and older groups (MD, 0.20 \[95% CI, −2.65 to 3.05\]; *P* = .89) ([Figure 2B](#fig2-2325967120915698){ref-type="fig"} and [Table 3](#table3-2325967120915698){ref-type="table"}).

###### 

Clinical and Functional Outcomes*^a^*

![](10.1177_2325967120915698-table3)

                         No. of Studies   No. of Patients   MD/RR (95% CI)              *P* Value
  ---------------------- ---------------- ----------------- --------------------------- -----------
  IKDC                                                                                  
   Absolute score*^b^*   4                287               --2.18 (--4.29 to --0.07)   .04
   Improvement*^c^*      4                287               0.20 (--2.65 to 3.05)       .89
  Lysholm                                                                               
   Absolute score*^b^*   4                287               --1.87 (--3.90 to 0.15)     .07
   Improvement*^c^*      4                287               --1.98 (--6.93 to 2.98)     .43
  Tegner                                                                                
   Absolute score*^b^*   2                157               --0.53 (--1.09 to 0.04)     .07
   Improvement*^c^*      2                157               --0.10 (--0.69 to 0.49)     .75
  Knee AP stability      3                202               0.73 (0.23 to 2.34)         .59

*^a^*AP, anteroposterior; IKDC, International Knee Documentation Committee; MD, mean difference; RR, risk ratio.

*^b^*At 1 to 2 years after index surgery.

*^c^*Difference between the last follow-up and baseline.

![Forest plot of International Knee Documentation Committee (IKDC) scores. (A) Total score at the end of follow-up. (B) Improvement at the end of follow-up from baseline.](10.1177_2325967120915698-fig2){#fig2-2325967120915698}

Lysholm Knee Score {#section11-2325967120915698}
------------------

All 4 of the included studies reported preoperative and postoperative Lysholm scores for the 2 groups. Overall, the older and younger groups had similar preoperative Lysholm scores. The meta-analysis revealed that these 2 groups had similar Lysholm scores at the end of follow-up (MD, −1.87 \[95% CI, −3.90 to 0.15\]; *P* = .07) ([Figure 3A](#fig3-2325967120915698){ref-type="fig"} and [Table 3](#table3-2325967120915698){ref-type="table"}). Moreover, the improvement in Lysholm scores was not significantly different between the older and younger patients (MD, −1.98 \[95% CI, −6.93 to 2.98\]; *P* = .43) ([Figure 3B](#fig3-2325967120915698){ref-type="fig"} and [Table 3](#table3-2325967120915698){ref-type="table"}). Significant heterogeneity existed across these studies (*I* ^2^ = 63%; *P* = .04).

![Forest plot of Lysholm knee scores. (A) Total score at the end of follow-up. (B) Improvement at the end of follow-up from baseline.](10.1177_2325967120915698-fig3){#fig3-2325967120915698}

Return to Physical Activity {#section12-2325967120915698}
---------------------------

Of the 4 included studies, 3 evaluated return to physical activity between older and younger patients.^[@bibr3-2325967120915698],[@bibr17-2325967120915698],[@bibr32-2325967120915698]^ One study used the IKDC score,^[@bibr32-2325967120915698]^ and the other 2 studies used the Tegner activity scale.^[@bibr3-2325967120915698],[@bibr17-2325967120915698]^ The meta-analysis revealed no significant difference in Tegner scores at the end of follow-up (MD, −0.53 \[95% CI, −1.09 to 0.04\]; *P* = .07) ([Figure 4A](#fig4-2325967120915698){ref-type="fig"} and [Table 3](#table3-2325967120915698){ref-type="table"}) or in the improvement of Tegner scores between the younger and older groups (MD, −0.10 \[95% CI, −0.69 to 0.49\]; *P* = .75) ([Figure 4B](#fig4-2325967120915698){ref-type="fig"} and [Table 3](#table3-2325967120915698){ref-type="table"}).

![Forest plot of Tegner activity scores. (A) Total score at the end of follow-up. (B) Improvement at the end of follow-up from baseline.](10.1177_2325967120915698-fig4){#fig4-2325967120915698}

Knee AP Stability {#section13-2325967120915698}
-----------------

Postoperative knee AP stability was measured by the mean side-to-side difference at maximal manual traction. Instability was defined as a mean side-to-side difference of greater than 5 mm. We found that 3 of the included studies reported outcomes in knee AP stability.^[@bibr17-2325967120915698],[@bibr20-2325967120915698],[@bibr32-2325967120915698]^ In 2 studies,^[@bibr17-2325967120915698],[@bibr32-2325967120915698]^ patients were evaluated with a KT-1000 arthrometer (MEDmetric) and in 1 study^[@bibr20-2325967120915698]^ with a KT-2000 arthrometer (MEDmetric). The incidence of knee AP laxity was 5.2% (5/96) in the older group and 7.5% (8/106) in the younger group. The meta-analysis revealed no difference between the 2 groups (RR, 0.73 \[95% CI, 0.23-2.34\]; *P* = .59) ([Figure 5](#fig5-2325967120915698){ref-type="fig"} and [Table 3](#table3-2325967120915698){ref-type="table"}).

![Forest plot of postoperative knee laxity.](10.1177_2325967120915698-fig5){#fig5-2325967120915698}

Complications {#section14-2325967120915698}
-------------

All 4 studies assessed postoperative complications, including ACL graft failure, arthrofibrosis, and the need for revision surgery after ACLR. Osti et al^[@bibr32-2325967120915698]^ reported 1 case of ACL graft failure in the older group. The incidence of arthrofibrosis was 12% (4/33) in the older group and 13% (7/52) in the younger group in the study by Cinque et al^[@bibr3-2325967120915698]^; no significant difference in the rate of arthrofibrosis was noted between the groups. No complications were recorded in the other 2 studies.^[@bibr17-2325967120915698],[@bibr20-2325967120915698]^

GRADE Findings {#section15-2325967120915698}
--------------

We used the GRADE approach to rate the overall quality of the evidence indicating that ACLR outcomes did not differ between patients older versus younger than 50 years. Overall, the quality of evidence was very low. The quality of evidence was downgraded by the high risk of selection bias (lack of randomization), performance bias (lack of blinding in participants), and imprecision. Details of the judgment are presented in [Tables 4](#table4-2325967120915698){ref-type="table"} and [5](#table5-2325967120915698){ref-type="table"}.

###### 

Overall Quality of Evidence According to GRADE Assessment*^a^*

![](10.1177_2325967120915698-table4)

                  No. of Patients/Studies   Certainty Assessment                                                     
  --------------- ------------------------- ---------------------- ------------- ------------- -------------- ------ ----------
  IKDC score      287/4 (observational)     Not serious            Not serious   Not serious   Serious^*c*^   None   Very low
  Lysholm score   287/4 (observational)     Not serious            Not serious   Not serious   Serious^*c*^   None   Very low
  Tegner score    157/2 (observational)     Not serious            Not serious   Not serious   Serious^*c*^   None   Very low
  Knee laxity     202/3 (observational)     Not serious            Not serious   Not serious   Serious^*c*^   None   Very low

*^a^*GRADE, Grading of Recommendations Assessment, Development and Evaluation; IKDC, International Knee Documentation Committee.

*^b^*Overall certainty of evidence: very low, low, moderate, and strong.

^*c*^Did not meet optimal information size criterion.

###### 

Overall Study Findings*^a^*

![](10.1177_2325967120915698-table5)

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
                  No. of Patients   Relative Effect\   Anticipated Absolute Effect                               
                                    (95% CI)                                                                     
  --------------- ----------------- ------------------ ----------------------------- --------------------------- --------------------------------------------
  IKDC score      158               129                ---                           Mean IKDC score, 20.76      MD, 0.2 higher (2.65 lower to 3.05 higher)

  Lysholm score   158               129                ---                           Mean Lysholm score, 35      MD, 1.98 lower (6.93 lower to 2.98 higher)

  Tegner score    88                69                 ---                           Mean Tegner score, --0.02   MD, 0.10 lower (0.69 lower to 0.49 higher)

  Knee laxity     8/106 (7.5%)      5/96 (5.2%)        RR, 0.73\                     75 per 1000                 20 fewer per 1000 (58 fewer to 101 more)
                                                       (0.23 to 2.34)                                            
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

*^a^*IKDC, International Knee Documentation Committee; MD, mean difference; RR, risk ratio.

Discussion {#section16-2325967120915698}
==========

We systematically evaluated and compared the efficacy and safety of arthroscopic ACLR between patients older than 50 years and those younger than 50 years. Our study results indicated that patients older than 50 years had comparable results in terms of knee stability and improvement of knee function, based on IKDC, Lysholm, and Tegner scores, to those of younger patients. Because of their low incidence, we are uncertain if there is a difference in terms of complications between the 2 groups. Thus, we found that ACLR was an effective procedure for treating ACL insufficiency in patients older than 50 years.

The potentially high risk of unfavorable outcomes, including arthrofibrosis and OA progression, has been a major concern in older patients undergoing ACLR.^[@bibr1-2325967120915698],[@bibr6-2325967120915698]^ Pre-existing chondral lesions and a prolonged time from injury to surgery are risk factors for OA progression after ACLR,^[@bibr4-2325967120915698]^ and preoperative cartilage lesions have been associated with poor clinical outcomes after ACLR.^[@bibr8-2325967120915698]^ In the current review, 3 of the included studies reported preoperative cartilage status: 1 study excluded patients with high-grade chondral lesions (Outerbridge grade 3 and 4).^[@bibr17-2325967120915698]^ The other 2 studies included patients who had undergone concomitant treatment for various cartilage conditions, including radiofrequency ablation and microfracture.^[@bibr3-2325967120915698],[@bibr32-2325967120915698]^ In addition, a prolonged time from injury to surgery of more than 1 year has been associated with an increased number and severity of cartilage lesions in ACL-deficient knees.^[@bibr26-2325967120915698],[@bibr27-2325967120915698]^ In this review, patients in the study by Kim et al^[@bibr20-2325967120915698]^ underwent surgery within an average of 20 months from injury, and those in the study by Iorio et al^[@bibr17-2325967120915698]^ underwent surgery no longer than 2 years from injury. One of the studies enrolled patients with both acute and chronic ACL injuries.^[@bibr3-2325967120915698]^ The variety of pre-existing chondral injuries and prolonged times to surgery in the included studies, which affected the clinical outcomes in an unpredictable manner, may have caused difficulties in the interpretation of findings.

In this review, 2 of the included studies reported outcomes at more than 3 years. Cinque et al^[@bibr3-2325967120915698]^ and Osti et al^[@bibr32-2325967120915698]^ both revealed no significant OA progression after ACLR in patients older than 50 years. An 11.3% (95% CI, 6.4%-19.1%) rate of OA progression after ACLR was reported in a 2018 systematic review.^[@bibr4-2325967120915698]^ Patient age and time from injury to surgery were associated with an increased likelihood of posttraumatic OA after ACLR.^[@bibr3-2325967120915698]^ In this review, the influence of pre-existing chondral injuries and time to surgery was similar across the 2 groups in each study, which may erase some bias in the interpretation of the combined results. Moreover, the improvement in clinical outcomes did not differ between the 2 groups, which implies that patients older than 50 years can have similar clinical outcomes to those of younger patients, regardless of pre-existing chondral lesions and potential OA changes after ACLR.

Despite dissimilar clinical outcomes, both meniscal repair and meniscectomy are acceptable treatments for concomitant meniscal injuries in patients with a chronic ACL injury.^[@bibr5-2325967120915698],[@bibr26-2325967120915698],[@bibr35-2325967120915698],[@bibr38-2325967120915698]^ Cohen et al^[@bibr5-2325967120915698]^ reported an increased incidence of arthrosis and poor function at long-term follow-up (10-15 years) after ACLR with meniscectomy. Singh et al^[@bibr38-2325967120915698]^ revealed that ACL deficiency with concomitant meniscal injuries was not related to poor outcomes at short-term follow-up (3.5 years). A systematic review published in 2019 compared the outcomes after concurrent meniscectomy versus meniscal repair in ACLR.^[@bibr35-2325967120915698]^ It revealed that the 2 groups had equivocal results at short-term follow-up (2 years), except for the Knee injury and Osteoarthritis Outcome Score, which favored meniscal resection over meniscal repair.^[@bibr35-2325967120915698]^ The meniscal repair group had less anterior knee joint laxity but a higher reoperation rate.^[@bibr35-2325967120915698]^ In the current review, 3 of the included studies reported the details of concurrent meniscal treatment.^[@bibr3-2325967120915698],[@bibr20-2325967120915698],[@bibr32-2325967120915698]^ The older group had a total of 79 meniscal injuries, of which 38 were treated by meniscal repair and 41 by meniscectomy. The younger group had a total of 91 meniscal injuries, of which 61 were treated by meniscal repair and 30 by meniscectomy. Although the younger group had a higher incidence of meniscal repair procedures than did the older group, the 2 groups had comparable results in terms of clinical function and anterior knee laxity. Thus, we found that patients older than 50 years could still have satisfactory function after ACLR, regardless of the type of concurrent meniscal treatment.

Among the studies included in the current review, various types of tendon grafts were used: namely, the BPTB autograft and allograft,^[@bibr3-2325967120915698]^ the doubled hamstring tendon autograft,^[@bibr17-2325967120915698]^ and the quadrupled hamstring tendon autograft.^[@bibr20-2325967120915698]^ According to previous studies,^[@bibr11-2325967120915698],[@bibr33-2325967120915698],[@bibr42-2325967120915698]^ both the BPTB and GST grafts can lead to satisfactory clinical outcomes. However, considering the reduced donor site morbidity and potentially fewer problems encountered with the extensor mechanism in ACLR with hamstring tendon autograft or allograft, several authors have suggested these procedures in older patients with relatively low functional demands.^[@bibr1-2325967120915698],[@bibr19-2325967120915698],[@bibr24-2325967120915698],[@bibr28-2325967120915698]^ Furthermore, despite a higher risk of graft failure, the use of allografts for primary ACLR is gaining popularity, given that the clinical outcomes are comparable between allografts and autografts.^[@bibr43-2325967120915698]^ For patients aged ≥50 years, relatively lower physical demands do not push the inherent limitations of the allograft, and the benefit of reduced donor site discomfort could counteract the potential risks of disease transmission and later tissue integration. In this review, the graft failure rate was 0% in 3 of the included studies,^[@bibr3-2325967120915698],[@bibr17-2325967120915698],[@bibr20-2325967120915698]^ and 1 graft failure was reported in the older group in the study by Osti et al.^[@bibr32-2325967120915698]^ Moreover, based on the combined data in the current study, satisfactory outcomes, including in terms of clinical function and joint stability, were achieved with all types of tendon grafts including the BPTB autograft, BPTB allograft, 2-stranded hamstring tendon autograft, and 4-stranded hamstring tendon autograft, without a significant difference between the 2 study groups. Therefore, restoring joint stability might be of more importance than focusing on graft choice.

The evaluation of IKDC scores was conducted for both knee function and symptoms based on the level of sport participation and inconvenience in daily activities and psychological anxiety.^[@bibr2-2325967120915698]^ We found that older patients could still obtain satisfactory functional scores, considering that they may have lower expectations in terms of daily activities or choose a less demanding sport for their knees as compensation. In this review, although the combined results indicated that the older group had slightly inferior IKDC scores than the younger group at the end of follow-up, only 1 of the included studies reported that the difference reached a significant level.^[@bibr20-2325967120915698]^ Overall, the improvement was not significantly different between these 2 groups. That is, patients older than 50 years still had knee functional improvements postoperatively, similarly to younger patients. Therefore, in the absence of pre-existing physical contraindications, ACLR is an option for patients in their 50s who wish to improve their quality of life and regain the level of physical activity they had before the injury.^[@bibr3-2325967120915698]^

Heterogeneity {#section17-2325967120915698}
-------------

Various factors might have led to the level of heterogeneity observed among the studies analyzed in this review. First, the concomitant knee status, including ligament and cartilage status, varied considerably among the 4 studies. Second, the surgical procedures were not identical across the studies. Therefore, surgical factors such as opioid dosage and surgeon experience might have contributed to heterogeneity.

Strengths and Limitations {#section18-2325967120915698}
-------------------------

This study has several strengths. First, it is the first systematic review and meta-analysis to compare the outcomes after ACLR between patients older than 50 years and younger patients. Second, we searched the 3 largest and most comprehensive databases for relevant studies. Third, the GRADE approach was used to evaluate the strength of the evidence for each outcome.

There are several limitations in this systematic review. First, all included studies followed a retrospective design, which implies inherent limitations of methodological quality. Second, as previously mentioned, the variation in numerous factors, including surgical and clinical factors, might have increased the heterogeneity. The number of variables limits the generalizability of our findings. Third, this review did not include studies with a control group of nonoperatively managed patients. Therefore, we could not comment on this issue, considering that nonoperative treatment still plays a role in older patients without high functional demands. Fourth, all included studies only reported the short-term to midterm outcomes after ACLR. We do not know whether surgery changed the long-term outcomes, for example, in terms of knee arthrosis. Fifth, because of their low incidence in all included studies, we are uncertain if there is a difference in terms of complications between the 2 groups.

Conclusion {#section19-2325967120915698}
==========

The current evidence demonstrates that patients older than 50 years had comparable outcomes after arthroscopic ACLR with those of patients younger than 50 years. In the absence of contraindications, patients older than 50 years should consider undergoing ACLR to regain daily activity function and improve their quality of life. This study offers orthopaedic surgeons a reference when making decisions on the treatment of ACL insufficiency in patients older than 50 years.
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Database Search Strategy {#section20-2325967120915698}
========================

Cochrane Central Register of Controlled Trials Search Strategy (April 30, 2019) {#section21-2325967120915698}
-------------------------------------------------------------------------------

1.  MeSH descriptor: \[Anterior Cruciate Ligament\] this term only (647)

2.  MeSH descriptor: \[Anterior Cruciate Ligament Reconstruction\] this term only (316)

3.  ((anterior near/2 cruciate\* near/2 ligament\*) or ACL): ti, ab, kw (Word variations have been searched) (2598)

4.  \#1 or \#2 or \#3 (2598)

5.  (ag\* or yea\* or old or older): ti, ab, kw (865306)

6.  (50 or fifty or fifties): ti, ab, tw (194117)

7.  \#4 and \#5 and \#6 \[trial\] (232)

MEDLINE Search Strategy (April 30, 2019) {#section23-2325967120915698}
----------------------------------------

1.  exp Anterior Cruciate Ligament/ (10306)

2.  exp Anterior Cruciate Ligament Reconstruction/ (4028)

3.  ((anterior adj2 cruciate\$ adj2 ligament\$) or ACL).tw. (20909)

4.  or/1-3 (22482)

5.  (ag\* or yea\* or old\* or old).tw. (7523786)

6.  (50 or 50 s or fifty or fifties).tw. (1343941)

7.  and/4-6 (1054)

Embase Search Strategy (April 30, 2019) {#section24-2325967120915698}
---------------------------------------

1.  'Anterior cruciate ligament'/exp

2.  'Anterior cruciate ligament reconstruction'/exp

3.  'Anterior cruciate ligament rupture'/exp

4.  'Anterior cruciate ligament injury''/exp (2923)

5.  (anterior NEAR/2 cruciate\* NEAR/2 ligament\*) or ACL): ab, ti (18924)

6.  \#1 or \#2 or \#3 or \#4 or \#5 (28847)

7.  (age or aged or year or years or old\* or old): ab, ti (6646188)

8.  (50 or 50 s or fifty or fifties): ab, ti (2186718)

9.  \#6 and \#7 and \#8 (1569)
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